Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference

Rhea-AI Summary

Organogenesis Holdings (Nasdaq: ORGO) will participate in the Credit Suisse 30th Annual Healthcare Conference from November 8-11, 2021. A fireside chat featuring company management is scheduled for November 11 at 9:40 a.m. ET. The event will be held virtually, and a live audio webcast will be accessible via the ‘Upcoming Events’ section on Organogenesis’s Investor Relations page. An archived version of the webcast will be available for 30 days post-conference.

Organogenesis specializes in regenerative medicine, offering bioactive products for advanced wound care and surgical markets.

News Market Reaction – ORGO

+4.44%

+4.44% Session move

In the trading session that priced this news, ORGO gained 4.44%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CANTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the Credit Suisse 30^th Annual Healthcare Conference, which is being held virtually from November 8th-11th. Management will participate in a fireside chat on Thursday, November 11th at 9:40 a.m. Eastern Time.

A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

FAQ

When is Organogenesis participating in the Credit Suisse Healthcare Conference?

Organogenesis will participate in the Credit Suisse 30th Annual Healthcare Conference from November 8-11, 2021, with a fireside chat on November 11 at 9:40 a.m. Eastern Time.

How can I watch the Organogenesis conference presentation?

You can watch the Organogenesis conference presentation by visiting the 'Upcoming Events' section on their Investor Relations page at www.organogenesis.com.

Will the Organogenesis presentation be available after the event?

Yes, an archive of the Organogenesis presentation will be available for replay for approximately 30 days following the conference.

What does Organogenesis specialize in?

Organogenesis specializes in regenerative medicine, focusing on developing products for advanced wound care and surgical markets, including orthopedics and spine.